Omega’s Otello Stampacchia on the ‘reset’ changing biotech for the better
Tough times in the industry are forcing changes in investment and governance that should result in a healthier sector, the Omega Funds founder said.
Previous Post
New Trilliant Health Report Exposes Widespread Price Variation in U.S. Healthcare
Next Post
Ovarian Cancer Early Detection, Diagnosis, and Staging
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago